Neuropathic Pain Scholarly Journal

Neuropathic pain is associated with impaired quality of life, and is often poorly managed. Around 7–8% of adults have pain with neuropathic characteristics. A quarter of people with diabetes and 35% of people with HIV have neuropathic pain.1The management of neuropathic pain can be challenging and, as with all pain, should be approached with a biopsychosocial framework. There are several options for drug treatment as part of an overall approach to improve patients’ quality of life and function.2International guidelines have clarified the definition of neuropathic pain and updated their recommendations for drug treatment based on evidence from a systematic review and meta-analysis.3,4 Being aware of these changes is important in the clinical assessment and treatment. Neuropathic pain is now defined by the International Association for the Study of Pain (IASP) as ‘pain caused by a lesion or disease of the somatosensory nervous system’.3 This replaces the older definition of ‘pain initiated or caused by a primary lesion, dysfunction or transitory perturbation of the peripheral or central nervous system’ 

High Impact List of Articles

Relevant Topics in

Table of Contents

For Authors

For Librarians

Open Access Journals